Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality
Kertes et al., Clinical Infectious Diseases, doi:10.1093/cid/ciac625
https://c19early.org/kertes.html